🧪 Lab Sheet: Hepion to Debut on OTCQB Venture Market June 25 as “HEPA”
iBio (IBIO) reports its engineered amylin-receptor antibody slashed food intake 60% in obese-mouse trials, matching advanced DACRA peptide results.
Jun 26, 2025
STREET SHEET RESEARCH MEMBERS ONLY
Premium subscribers get 3 TRADE IDEAS from TOP ANALYSTS with 30%+ UPSIDE per week. We find the best track records on Wall Street, distill their highest-conviction picks only, and deliver them to you weekly.
GET 50% OFF: JUST $99 FOR YOUR FIRST YEAR
